Порівняння методів

	Аналіз методом проточної цитометрії	Електрофізіологія методом ділянки мембрани (Patch-Clamp)	Популяційне фармакодинамічне моделювання
Галузь	Фармакологія	Фармакологія	Фармакологія
Родина	Process / pipeline	Process / pipeline	Process / pipeline
Рік появи	1976	1976	1992
Автор методу	Leonard Herzenberg	Erwin Neher and Bert Sakmann	Lewis Sheiner and Stephen Roush
Тип	cell analysis and sorting	ion channel screening	dose-response modeling
Основоположне джерело	Herzenberg, L. A., Parks, D., Sahaf, B., Perez, O., Roederer, M., & Herzenberg, L. A. (2002). The history and future of the fluorescence-activated cell sorter and flow cytometry: a view from Stanford. Clinical Chemistry, 48(10), 1819-1827.	Neher, E., & Sakmann, B. (1976). Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature, 260(5554), 799-802.	Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57.
Інші назви	FACS, fluorescence-activated cell sorting, cell analysis	patch clamp, whole-cell recording, ion channel assay	PopPD, population PD, hierarchical PD modeling
Пов'язані	3	3	3
Підсумок	Flow cytometry is a laser-based technology for analyzing and sorting individual cells based on fluorescent markers. Developed by Leonard Herzenberg in the 1970s, flow cytometry enables rapid assessment of cell phenotype, drug effects on cell populations, and therapeutic cell characterization in immunology and hematology.	Patch-clamp electrophysiology is a technique for measuring ionic currents through ion channels in cell membranes, developed by Neher and Sakmann in 1976. It enables direct observation of single-channel and whole-cell currents at millisecond resolution, making it essential for characterizing drug effects on ion channels and cardiac safety assessment.	Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.